Sign in

CIK 0001699382

  • Non-accelerated filer
  • Smaller reporting company

PMV Pharmaceuticals, Inc.

Sign in to watch
Ticker
PMVP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463218129
Phone
+1 609-642-6670
Business address
400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON, NJ, 08540
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale COO, CFO sold 4,500 shares at $33.75 ($151,875)
  3. 4 Open-market sale Director sold 29,666 shares at an average $34.21 ($1,014,737)
  4. 4 Open-market sale Director sold 136,436 shares at an average $34.31 ($4,681,653)
  5. 4 Open-market sale Chief Medical Officer sold 4,000 shares at an average $33.86 ($135,445)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Director sold 60,628 shares at an average $33.63 ($2,038,792)
  9. 4 Open-market sale Director sold 58,283 shares at an average $31.87 ($1,857,520)
  10. 4 Open-market sale Director sold 136,476 shares at an average $34.03 ($4,644,130)
  11. 4 Other disposition 10% owner disposed of 1,010,000 shares (other)
  12. 4 Exercise or conversion COO, CFO acquired 1,600 shares (option exercise)
  13. 4 Exercise or conversion President and CEO acquired 2,470 shares (option exercise)
  14. 4 Derivatives Options or other derivatives
  15. 4/A Open-market buy Director bought 55,555 shares at $18.00 ($999,990)
  16. 4/A Open-market buy 10% owner bought 55,555 shares at $18.00 ($999,990)
  17. 4 Conversion Former 10% Owner acquired 2,528,290 shares (conversion)
  18. 4 Conversion Former 10% Owner acquired 760,267 shares (conversion)
  19. 4 Conversion Former 10% Owner acquired 4,179,416 shares (conversion)
  20. 4 Insider Changes in Ownership

Page 8 of 10 · 190 filings